Skip to main content
Log in

Amyloid-PET not cost effective in patients with mild cognitive impairment in South Korea

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Li Y-S, et al. Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment. Cost Effectiveness and Resource Allocation : 19 Aug 2021. Available from: URL: https://doi.org/10.1186/s12962-021-00300-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amyloid-PET not cost effective in patients with mild cognitive impairment in South Korea. PharmacoEcon Outcomes News 886, 2 (2021). https://doi.org/10.1007/s40274-021-07980-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-07980-7

Navigation